Twelve deals win unconditional antitrust clearance in China Jan. 18-24
MLex Summary: US private-equity firm The Carlyle Group’s acquisition of mechanical-drive technology specialist Flender; a joint venture between Shanghai Pharmaceutical Group and Zhejiang Jiuzhou Pharmaceutical; and CVC Capital Partners’ purchase of...To view the full article, register now.
Already a subscriber? Click here to view full article